TFAP2A and pancreatic adenocarcinoma: Kaplan-Meier overall survival curves that were based on TFAP2A levels from the TCGA PAAD database confirmed that patients with high expressions of TFAP2A had significantly low survival outcomes (Supplementary Figure 2C).